CLPT EBITDA Margin
Clearpoint Neuro Inc · EBITDA Margin
CLPT EBITDA Margin
Latest reported-64.01%period ending
CLPT TTM EBITDA Margin (-118.26% → -64.01%)
TTM ebitda margin
High-resolution chart · PNG
CLPT ebitda margin history
Trailing twelve months (TTM). Each value covers four complete reported quarters.
| Period ending | EBITDA Margin |
|---|---|
| -64.0058% | |
| -57.362% | |
| -59.2951% | |
| -60.0285% | |
| -60.0542% | |
| -58.9806% | |
| -54.1924% | |
| -53.5377% | |
| -57.7078% | |
| -72.4972% | |
| -86.1282% | |
| -92.6072% | |
| -91.697% | |
| -81.9214% | |
| -75.2323% | |
| -76.479% | |
| -78.4565% | |
| -82.7746% | |
| -78.1888% | |
| -63.6274% | |
| -52.1634% | |
| -41.5891% | |
| -37.3187% | |
| -41.0876% | |
| -40.1288% | |
| -38.4279% | |
| -38.6386% | |
| -38.29% | |
| -46.3228% | |
| -56.3027% | |
| -68.9986% | |
| -87.9819% | |
| -89.6474% | |
| -87.6721% | |
| -83.7178% | |
| -78.9328% | |
| -95.2155% | |
| -103.8828% | |
| -122.0355% | |
| -123.4194% | |
| -124.9713% | |
| -156.3596% | |
| -175.7611% | |
| -231.1221% | |
| -290.5018% | |
| -246.972% | |
| -258.4365% | |
| -227.6781% | |
| -192.3636% | |
| -225.7365% | |
| -179.9802% | |
| -118.1048% | |
| -95.9513% | |
| -55.3006% | |
| -54.4054% | |
| -84.1974% | |
| -83.8736% | |
| -118.2621% |